Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-o-tetrahydropyranyladriamycin
2. 4'-o-tetrahydropyranyldoxorubicin
3. 4'-o-tetrapyranyldoxorubicin
4. Pirarubicin
5. Pirarubicin Hydrochloride
6. Thprubicine
7. Thepirubicin
8. Theprubicin
9. Thp-adm
10. Thp-adriamycin
11. Thp-dox
12. Thp-doxorubicin
1. Pirarubicin
2. 72496-41-4
3. Pinorubicin
4. Pinorubin
5. Pirarubicin, >=95% (hplc)
6. (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-6-methyl-5-(oxan-2-yloxy)oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione
7. Sr-01000944915
8. Sr-01000944915-1
Molecular Weight | 627.6 g/mol |
---|---|
Molecular Formula | C32H37NO12 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 7 |
Exact Mass | 627.23157562 g/mol |
Monoisotopic Mass | 627.23157562 g/mol |
Topological Polar Surface Area | 204 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 1120 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01D - Cytotoxic antibiotics and related substances
L01DB - Anthracyclines and related substances
L01DB08 - Pirarubicin
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?